Bharat Biotech's Covaxin shows 77.8% efficacy in phase 3 trial data: Report
Covaxin has shown the efficacy from the trial conducted on 25,800 subjects, according to a news report
Covaxin has shown the efficacy from the trial conducted on 25,800 subjects, according to a news report https://ift.tt/35FKPo5 June 22, 2021 at 12:29AM
Covaxin has shown the efficacy from the trial conducted on 25,800 subjects, according to a news report https://ift.tt/35FKPo5 June 22, 2021 at 12:29AM
Comments
Post a Comment